The current stock price of CHNG is 27.49 USD. In the past month the price increased by 11.07%. In the past year, price increased by 30.16%.
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| VEEV | VEEVA SYSTEMS INC-CLASS A | 31 | 39.33B | ||
| DOCS | DOXIMITY INC-CLASS A | 31.14 | 9.57B | ||
| WAY | WAYSTAR HOLDING CORP | 27.6 | 7.06B | ||
| HTFL | HEARTFLOW INC | N/A | 2.71B | ||
| CERT | CERTARA INC | 18.24 | 1.45B | ||
| TDOC | TELADOC HEALTH INC | N/A | 1.32B | ||
| SDGR | SCHRODINGER INC | N/A | 1.28B | ||
| PHR | PHREESIA INC | N/A | 1.24B | ||
| LFMDP | LIFEMD INC - LFMD 8 7/8 PERP | N/A | 1.10B | ||
| CCLDO | CARECLOUD INC - CCLD 8 3/4 PERP | 634.34 | 1.07B | ||
| GDRX | GOODRX HOLDINGS INC-CLASS A | 8.03 | 953.80M | ||
| CTEV | CLARITEV CORP | N/A | 863.03M |
Change Healthcare, Inc. engages in the development of a healthcare technology platform that offers data and analytics-driven solutions. The company is headquartered in Nashville, Tennessee and currently employs 14,000 full-time employees. The company went IPO on 2019-06-27. The firm is focused on the transformation of the healthcare system through its Change Healthcare platform. The firm operates through three business segments: Software and Analytics, Network Solutions, and Technology-Enabled Services. Its Software and Analytics segment provide solutions for revenue cycle management, provider network management, payment accuracy, value-based payments, clinical decision support, consumer engagement, risk adjustment and quality performance, and imaging and clinical workflow. Its Network Solutions segment provide solutions for financial, administrative, and clinical and pharmacy transactions, electronic payments and aggregation and analytics of clinical and financial data. Its Technology-Enabled Services segment provides solutions for financial and administrative management, value-based care, communication and payment, pharmacy benefits administration and healthcare consulting.
CHANGE HEALTHCARE INC
424 Church Street, Suite 1400
Nashville TENNESSEE 37219 US
CEO: Neil E. de Crescenzo
Employees: 14000
Phone: 16159323000.0
Change Healthcare, Inc. engages in the development of a healthcare technology platform that offers data and analytics-driven solutions. The company is headquartered in Nashville, Tennessee and currently employs 14,000 full-time employees. The company went IPO on 2019-06-27. The firm is focused on the transformation of the healthcare system through its Change Healthcare platform. The firm operates through three business segments: Software and Analytics, Network Solutions, and Technology-Enabled Services. Its Software and Analytics segment provide solutions for revenue cycle management, provider network management, payment accuracy, value-based payments, clinical decision support, consumer engagement, risk adjustment and quality performance, and imaging and clinical workflow. Its Network Solutions segment provide solutions for financial, administrative, and clinical and pharmacy transactions, electronic payments and aggregation and analytics of clinical and financial data. Its Technology-Enabled Services segment provides solutions for financial and administrative management, value-based care, communication and payment, pharmacy benefits administration and healthcare consulting.
The current stock price of CHNG is 27.49 USD. The price increased by 0.26% in the last trading session.
CHNG does not pay a dividend.
CHNG has a ChartMill Technical rating of 10 out of 10 and a ChartMill Fundamental rating of 4 out of 10.
CHNG stock is listed on the Nasdaq exchange.
The PE ratio for CHANGE HEALTHCARE INC (CHNG) is 18.57. This is based on the reported non-GAAP earnings per share of 1.48 and the current share price of 27.49 USD.
ChartMill assigns a technical rating of 10 / 10 to CHNG. When comparing the yearly performance of all stocks, CHNG is one of the better performing stocks in the market, outperforming 95.77% of all stocks.
ChartMill assigns a fundamental rating of 4 / 10 to CHNG. While CHNG is still in line with the averages on profitability rating, there are concerns on its financial health.
Over the last trailing twelve months CHNG reported a non-GAAP Earnings per Share(EPS) of 1.48. The EPS decreased by -0.67% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | -2.2% | ||
| ROA | -0.8% | ||
| ROE | N/A | ||
| Debt/Equity | 1.36 |
17 analysts have analysed CHNG and the average price target is 27.85 USD. This implies a price increase of 1.32% is expected in the next year compared to the current price of 27.49.
For the next year, analysts expect an EPS growth of -1.57% and a revenue growth 3.51% for CHNG